BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 19766736)

  • 1. Structural and biochemical changes in mitochondria after cisplatin treatment of Dalton's lymphoma-bearing mice.
    Prasad SB; Rosangkima G; Kharbangar A
    Mitochondrion; 2010 Jan; 10(1):38-45. PubMed ID: 19766736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cisplatin- and dietary ascorbic acid-mediated changes in the mitochondria of Dalton's lymphoma-bearing mice.
    Martha KR; Rosangkima G; Amenla L; Rongpi T; Prasad SB
    Fundam Clin Pharmacol; 2013 Jun; 27(3):329-38. PubMed ID: 22211279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclophosphamide and ascorbic acid-mediated ultrastructural and biochemical changes in Dalton's lymphoma cells in vivo.
    Prasad SB; Rosangkima G; Nicol BM
    Eur J Pharmacol; 2010 Oct; 645(1-3):47-54. PubMed ID: 20655303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cantharidin-mediated ultrastructural and biochemical changes in mitochondria lead to apoptosis and necrosis in murine Dalton's lymphoma.
    Prasad SB; Verma AK
    Microsc Microanal; 2013 Dec; 19(6):1377-94. PubMed ID: 24029497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of cisplatin on mitochondrial protein, glutathione, and succinate dehydrogenase in Dalton lymphoma-bearing mice.
    Kharbangar A; Khynriam D; Prasad SB
    Cell Biol Toxicol; 2000; 16(6):363-73. PubMed ID: 11254162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex dimorphism in antitumor response of chemotherapeutic drug cisplatin in a murine host-bearing a T-cell lymphoma.
    Gupta V; Singh SM
    Anticancer Drugs; 2008 Jul; 19(6):583-92. PubMed ID: 18525317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor effect of cisplatin against murine ascites Dalton's lymphoma.
    Prasad SB; Giri A
    Indian J Exp Biol; 1994 Mar; 32(3):155-62. PubMed ID: 8070834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proapoptotic and antitumor activities of the HMG-CoA reductase inhibitor, lovastatin, against Dalton's lymphoma ascites tumor in mice.
    Ajith TA; Harikumar KB; Thasna H; Sabu MC; Babitha NV
    Clin Chim Acta; 2006 Apr; 366(1-2):322-8. PubMed ID: 16380106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of subtherapeutical dose of cisplatin and vitamin C against murine Dalton's lymphoma.
    Prasad SB; Giri A; Arjun J
    Pol J Pharmacol Pharm; 1992; 44(4):383-91. PubMed ID: 1287602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cisplatin-induced nephrotoxicity is associated with oxidative stress, redox state unbalance, impairment of energetic metabolism and apoptosis in rat kidney mitochondria.
    Santos NA; Catão CS; Martins NM; Curti C; Bianchi ML; Santos AC
    Arch Toxicol; 2007 Jul; 81(7):495-504. PubMed ID: 17216432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumour activity of some plants from Meghalaya and Mizoram against murine ascites Dalton's lymphoma.
    Rosangkima G; Prasad SB
    Indian J Exp Biol; 2004 Oct; 42(10):981-8. PubMed ID: 15511001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor activity of a new platinum(II) complex with low nephrotoxicity and genotoxicity.
    Marzano C; Bettio F; Baccichetti F; Trevisan A; Giovagnini L; Fregona D
    Chem Biol Interact; 2004 Jun; 148(1-2):37-48. PubMed ID: 15223355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sialic acid changes in Dalton's lymphoma-bearing mice after cyclophosphamide and cisplatin treatment.
    Nicol BM; Prasad SB
    Braz J Med Biol Res; 2002 May; 35(5):549-53. PubMed ID: 12011939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cisplatin-induced nephrotoxicity in porcine proximal tubular cells: mitochondrial dysfunction by inhibition of complexes I to IV of the respiratory chain.
    Kruidering M; Van de Water B; de Heer E; Mulder GJ; Nagelkerke JF
    J Pharmacol Exp Ther; 1997 Feb; 280(2):638-49. PubMed ID: 9023274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemoimmunotherapeutical studies on Dalton's lymphoma with cis-platin.
    Bahadur A
    Pol J Pharmacol Pharm; 1985; 37(4):463-8. PubMed ID: 4080643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemo-immunotherapeutical studies on Dalton's lymphoma in mice using cisplatin and ascorbic acid: synergistic antitumor effect in vivo and in vitro.
    Sarna S; Bhola RK
    Arch Immunol Ther Exp (Warsz); 1993; 41(5-6):327-33. PubMed ID: 8010874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of high cell density on the growth properties of tumor cells: a role in tumor cytotoxicity of chemotherapeutic drugs.
    Singh V; Singh SM
    Anticancer Drugs; 2007 Nov; 18(10):1123-32. PubMed ID: 17893512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sesame oil attenuates Cisplatin-induced hepatic and renal injuries by inhibiting nitric oxide-associated lipid peroxidation in mice.
    Hsu DZ; Chen KT; Lin TH; Li YH; Liu MY
    Shock; 2007 Feb; 27(2):199-204. PubMed ID: 17224796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of cell mediated immunity in vitro and in vivo after cis-platin treatment.
    Bahadur A; Sodhi A
    Pol J Pharmacol Pharm; 1985; 37(4):453-61. PubMed ID: 4080642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chlorambucil and ascorbic acid-mediated anticancer activity and hematological toxicity in Dalton's ascites lymphoma-bearing mice.
    Kalita S; Verma AK; Prasad SB
    Indian J Exp Biol; 2014 Feb; 52(2):112-24. PubMed ID: 24597143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.